The future of pharmacology. (Q40851159)

24 September 2017

title

The future of pharmacology. (English)

1 reference

24 September 2017

1 reference

24 September 2017

publication date

1 June 1998

1 reference

Trends in Pharmacological Sciences

24 September 2017

published in

1 reference

24 September 2017

1 reference

24 September 2017

1 reference

24 September 2017

page(s)

198-200

1 reference

Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901213-9

7 January 2021

Targeting HIV-1 protease: a test of drug-design methodologies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901213-9

7 January 2021

Interactions between Ras proteins and their effectors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901213-9

7 January 2021

A small region in phosducin inhibits G-protein betagamma-subunit function.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901213-9

7 January 2021

Synthesis and Structure−Activity Relationships of Potent Thrombin Inhibitors: Piperazides of 3-Amidinophenylalanine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901213-9

7 January 2021

Discovery and development of the novel potent orally active thrombin inhibitor N-(9-hydroxy-9-fluorenecarboxy)prolyl trans-4-aminocyclohexylmethyl amide (L-372,460): coapplication of structure-based design and rapid multiple analogue synthesis on so

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901213-9

7 January 2021

Losartan versus gene therapy: chronic control of high blood pressure in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901213-9

7 January 2021

Antisense-oligonucleotide therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901213-9

7 January 2021

Facilitating oligonucleotide delivery: helping antisense deliver on its promise

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901213-9

7 January 2021

Relationships between academic institutions and industry in the life sciences--an industry survey

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901213-9

7 January 2021

10.1016/S0165-6147(98)01213-9

Identifiers

DOI

1 reference

24 September 2017

1 reference